| |
| |
|
| Insider
Information: |
Anido Vicente Jr |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
237,799 |
|
|
Indirect Shares
|
10,500 |
|
|
| Direct
Value |
$3,563,516 |
|
|
|
Indirect Value
|
$160,125 |
|
|
| Total
Shares |
248,299 |
|
|
| Total
Value |
$3,723,641 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Apria Healthcare Group Inc |
AHG |
Director |
2008-10-28 |
0 |
2003-07-17 |
0 |
Premium* |
|
|
ISTA Pharmaceuticals Inc |
ISTA |
President & CEO, Direc... |
2012-06-06 |
0 |
2005-05-12 |
0 |
Premium* |
|
|
Aerie Pharmaceuticals Inc |
AERI |
Chief Executive Office... |
2021-02-23 |
233,396 |
2021-02-23 |
10,500 |
Premium* |
|
|
Assertio Holdings Inc |
ASRT |
Director |
2016-05-12 |
4,403 |
2015-12-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
90 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AHG |
Apria Healthcare Group In... |
Director |
– • – |
2004-02-20 |
4/A |
B |
$30.66 |
$30,660 |
D/D |
1,000 |
4,000 |
2.39 |
- |
|
| AHG |
Apria Healthcare Group In... |
Director |
– • – |
2004-02-20 |
4 |
A |
$30.66 |
$30,660 |
D/D |
1,000 |
4,000 |
|
- |
|
| ASRT |
Assertio Holdings Inc |
Director |
– • – |
2016-05-12 |
4 |
D |
$17.52 |
$18,133 |
D/D |
(1,035) |
4,403 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2018-02-23 |
4 |
D |
$53.85 |
$56,650 |
D/D |
(1,052) |
129,725 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-02-23 |
4 |
D |
$21.59 |
$22,713 |
D/D |
(1,052) |
221,323 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2019-02-23 |
4 |
D |
$40.04 |
$42,162 |
D/D |
(1,053) |
149,056 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2018-02-25 |
4 |
D |
$53.85 |
$72,751 |
D/D |
(1,351) |
126,320 |
0 |
- |
|
| ASRT |
Assertio Holdings Inc |
Director |
– • – |
2015-12-01 |
4 |
D |
$19.00 |
$25,859 |
D/D |
(1,361) |
2,502 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2017-02-25 |
4 |
D |
$44.55 |
$67,627 |
D/D |
(1,518) |
87,065 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2019-02-24 |
4 |
D |
$40.04 |
$61,141 |
D/D |
(1,527) |
147,529 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-02-24 |
4 |
D |
$20.30 |
$30,998 |
D/D |
(1,527) |
219,796 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-02-08 |
4 |
D |
$20.49 |
$31,678 |
D/D |
(1,546) |
222,375 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2019-02-25 |
4 |
D |
$40.18 |
$62,761 |
D/D |
(1,562) |
145,967 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2019-02-08 |
4 |
D |
$40.39 |
$65,593 |
D/D |
(1,624) |
150,109 |
0 |
- |
|
| ISTA |
ISTA Pharmaceuticals Inc |
President & CEO |
• • – |
2007-02-16 |
4 |
D |
$8.11 |
$13,479 |
D/D |
(1,662) |
32,438 |
0 |
- |
|
| ISTA |
ISTA Pharmaceuticals Inc |
President & CEO |
• • – |
2008-02-19 |
4 |
D |
$4.56 |
$7,579 |
D/D |
(1,662) |
65,054 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2021-02-23 |
4 |
D |
$15.66 |
$26,622 |
D/D |
(1,700) |
233,396 |
0 |
- |
|
| ISTA |
ISTA Pharmaceuticals Inc |
President & CEO |
• • – |
2010-02-16 |
4 |
D |
$3.96 |
$6,752 |
D/D |
(1,705) |
415,067 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-02-07 |
4 |
D |
$20.49 |
$35,038 |
D/D |
(1,710) |
223,921 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2017-02-24 |
4 |
D |
$44.55 |
$76,448 |
D/D |
(1,716) |
88,583 |
0 |
- |
|
| ISTA |
ISTA Pharmaceuticals Inc |
President & CEO |
• • – |
2005-05-12 |
4 |
B |
$7.57 |
$13,658 |
D/D |
1,800 |
13,300 |
2.81 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2018-02-24 |
4 |
D |
$53.85 |
$110,608 |
D/D |
(2,054) |
127,671 |
0 |
- |
|
| ISTA |
ISTA Pharmaceuticals Inc |
President & CEO |
• • – |
2008-02-04 |
4 |
D |
$5.27 |
$11,710 |
D/D |
(2,222) |
30,216 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-01-28 |
4 |
A |
$0.00 |
$0 |
I/I |
2,250 |
10,500 |
0 |
- |
|
| AERI |
Aerie Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2016-02-25 |
5 |
D |
$16.34 |
$36,847 |
D/D |
(2,255) |
73,018 |
0 |
- |
|
90 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
